Comparative Pharmacology
Head-to-head clinical analysis: OBY TRIM versus STATOBEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OBY TRIM versus STATOBEX.
OBY-TRIM vs STATOBEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
OBY-TRIM is a combination of phentermine, a sympathomimetic amine anorectic that stimulates the hypothalamus to release norepinephrine, suppressing appetite, and a diuretic (often a thiazide) to reduce fluid retention.
STATOBEX is a monoclonal antibody that binds to and inhibits the activity of signal transducer and activator of transcription 3 (STAT3), thereby blocking downstream signaling pathways involved in cell proliferation, survival, and angiogenesis.
Oral: 1 capsule (phentermine 18.75 mg / chlorpheniramine 6.25 mg) twice daily, 30 minutes before meals.
5 mg orally once daily, taken in the morning without regard to meals.
None Documented
None Documented
Terminal half-life is approximately 20–30 hours in adults with normal renal function. This allows for once-daily dosing in most patients.
Terminal half-life approximately 8-10 hours in healthy adults; prolonged in renal impairment (up to 20 hours).
Primarily renal (90% as unchanged drug and metabolites), with about 10% biliary/fecal. In an acidic urine, elimination half-life increases.
Primarily renal (60-70% unchanged), biliary/fecal (20-30%), with some enterohepatic recirculation.
Category C
Category C
Anorexiant
Anorexiant